YGYuliya Eduardovna Generalova

Yuliya Eduardovna Generalova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuliya Eduardovna Generalova has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative nephroprotective efficacy of malonic acid derivatives (etmaben and maloben) in renal ischemia-reperfusion injury in rats

    by A. Yu. Grishina, J. E. Generalova, A. S. Ivanov, I. A. Titovich, D. Yu. Ivkin, А. Ю. Гришина, Ю. Э. Генералова, А. С. Иванов, И. А. Титович, Д. Ю. Ивкин

    Introduction. This study assessed the nephroprotective potential of malonic acid derivatives (MADs) in acute and subacute ischemic renal injury. A model of prerenal failure was simulated using 60-minute warm renal ischemia. Aim. To study the nephroprotective effect of MADs in acute and subacute ischemic renal failure. Materials and methods. The experiment was conducted using a model of warm renal ischemia induced by 60-minute occlusion of the right renal artery. During a month-long monotherapy course, the effects of 4-[(3-ethoxy-3-oxopropanoyl) amino]benzoic acid (etmaben, 60 mg/kg) and sodium 4,4'-(propanediamido)dibenzoate (maloben, 60 mg/kg) were compared with the reference drug, ethylmethylhydroxypyridine succinate (Mexidol®, 50 mg/kg). To assess renal function on days 3 and 30 after ischemia, serum creatinine and urea concentrations, glomerular filtration rate (GFR), creatinine clearance, electrolyte excretion rate, and antioxidant gene expression were analyzed, and histological examination was performed. Results and discussion. The obtained data indicate the significant efficacy of MADs in the treatment of acute ischemic kidney injury. In the group of animals receiving etmaben, a statistically significant decrease in serum creatinine and urea levels, as well as an increase in glomerular filtration rate, was observed, with no significant effect on diuresis. Maloben, in turn, had a more pronounced effect on diuresis and electrolyte excretion during the acute period. Both studied compounds demonstrated the ability to improve renal excretory function, manifested by increased creatinine elimination and a reduction in the severity of the oligoanuric phase of acute nephropathy. Conclusion. It was found that the studied drugs activate renal excretory function, contribute to the normalization of creatinine clearance and the attenuation of the manifestations of acute oligoanuric syndrome, stabilizing the condition of animals with acute kidney injury.

  • Open Access

    Comparative Analysis of Trace Element Content in Pectoral Species

    by I. V. Gravel, D. V. Levushkin, Yu. E. Generalova, V. V. Kosenko, I. I. Terninko

    INTRODUCTION. Trace elements can influence the pharmacological effect of herbal medicinal products. However, their quality control is currently limited to assessing the content of only toxic elements (Pb, Cd, Hg, As), without evaluating the complete trace element profile. Therefore, studies on the elemental composition of complex herbal products available on the pharmaceutical market are highly relevant. AIM. To perform a comparative assessment of the trace element content (Al, Ba, Cu, Fe, Mn, Sr, Zn) in pharmacopoeial pectoral species. MATERIALS AND METHODS. The objects of the study were samples of pectoral species No. 1, No. 2, No. 3, and No. 4 produced by Russian manufacturers. The content of the seven elements specified in the aim was determined using inductively coupled plasma atomic emission spectrometry (ICP-AES). RESULTS. The content (mg/kg) of trace elements in the pectoral species samples varied within the following ranges: Fe 134.9–707.8; Mn 25.6–248.7; Cu 3.8–16.9; Zn 4.3–35.7; Al 184.2–769.8; Ba 8.4–43.8; Sr 74.3–254.6. The elements differed in concentration levels: Fe and Al — high; Sr and Mn — medium; Ba, Cu, and Zn — low. The estimated daily intake for humans was: Ba 0.08–0.43 mg/day; Cu 0.03–0.16 mg/day, which is 3–18 and 19–100 times lower, respectively, than the established acceptable daily intake levels (1.4 and 3.0 mg/day) set by Decision No. 138 of the Board of the Eurasian Economic Commission (EAEC). CONCLUSIONS. For the first time, a comparative analysis of the trace element content (Al, Ba, Cu, Fe, Mn, Sr, Zn) in pectoral species No. 1–4 from different manufacturers has been conducted. The trace element profile revealed that the content of trace elements in individual mixtures varied by a factor of 3–8, depending on the sources of raw materials selected by the manufacturer. Distinct accumulation patterns were identified for each mixture: pectoral species No. 1 showed the highest Fe content; No. 2 — the highest Sr content; and No. 4 — the highest levels of Mn, Cu, and Zn. These findings should be taken into account when using phytotherapy for the treatment and prevention of upper respiratory tract diseases.

  • Electrospun poly(vinyl alcohol)-chitosan nanofibers integrated with mangiferin: fabrication and properties

    by Thi Hong Nhung Vu, Svetlana N. Morozkina, Vera E. Sitnikova, Yuliya Е. Generalova, Quang Sang Nguyen, Mayya V. Uspenskaya


  • Development, validation and testing of the HPLC-UV bioanalytical method for quantification of etmaben in blood plasma and organs of rats

    by A. B. Zelentsova, A. Yu. Grishina, Yu. E. Generalova, D. Yu. Ivkin, I. I. Terninko

    Introduction. Currently, the search and development of innovative cardiotropic drugs is an urgent task for pharmaceutical science. One such drug is a derivative of malonic acid, etmaben, which was synthesized at the St. Petersburg State Chemical and Pharmaceutical University (SPCPU). To conduct preclinical and clinical studies, it is necessary to develop and validate a bioanalytical method that allows for the quantitative determination of etmaben in complex biological matrices with minimal time and resource requirements. Aim. The aim of the study is to develop and validate a method for the determination of etmaben in the blood plasma and organs of laboratory animals using high-performance liquid chromatography with ultraviolet detection (HPLC-UV) followed by testing and obtaining a pool of data on the distribution of etmaben in the organs and tissues of experimental animals. Materials and methods. The development and validation of the bioanalytical method, as well as the quantitative determination of etmaben, were performed on a Flexar liquid chromatograph (PerkinElmer, USA) equipped with a UV detector and a thermostatted autosampler, using a Kromasil 100, 150 × 2.1, C8, 3.5 μm column (AkzoNobel, Netherlands). Detection was performed at a wavelength of 270 nm. A pharmacological experiment to test the method was conducted on 20 outbred male rats (Kurchatov Institute – "Rappolovo", Russia), divided into a control group (intact animals, n = 10) and a group with experimental chronic heart failure (CHF) ( n = 10), a model of which was induced by ligation of the left coronary artery. All animals received etmaben intragastrically at a dose of 60 mg/kg for 30 days. Whole blood samples were collected for analysis on day 30, and organs (heart and kidneys) were isolated. Etmaben was quantified in plasma and tissue homogenates using HPLC-UV after sample preparation, including protein precipitation with acetonitrile (HPLC Grade, cat. no. A/0627/17, Thermo Fisher Scientific, USA). Results and discussion. Optimal conditions for the chromatographic determination of etmaben in biological matrices (blood plasma and tissue homogenates) using HPLC-UV were developed. The developed method was validated using the following validation parameters: selectivity, calibration curve, accuracy, precision, lower limit of quantification (LLOQ), carryover effect, no effect of sample dilution and stability. The degree of etmaben recovery from the matrix was also assessed. The LLOQ for etmaben was 5.0 ng/mL. The developed method was successfully applied to assess etmaben distribution in the organs and tissues of laboratory animals at specific stages of preclinical testing. In CHF, plasma concentrations of etmaben doubled, and in pathologically altered myocardium, they increased by 47 % compared to control animals. Conclusion. A bioanalytical method for determining etmaben using HPLC-UV was developed and validated. It was tested during preclinical trials to study the drug's distribution in organs and tissues of experimental animals. The observed selective accumulation of etmaben in damaged myocardium confirms its therapeutic relevance for the treatment of CHF.

  • Open Access

    Development of effective technologies for extraction of organic calcium from arctic shrimp processing waste

    by A. N. Shikov, U. K. F. Ahounou, A. A. Kaleta, Yu. E. Generalova, I. I. Terninko, I. E. Smekhova, O. N. Pozharitskaya

    Introduction. Calcium is a key macroelement that ensures bone mineral density, muscle and cardiovascular function, and is involved in enzymatic and neurotransmitter processes. Calcium deficiency is widespread and associated with the development of osteoporosis and other metabolic disorders. The administration of medicinal preparations with calcium compensates its deficiency in patients and contribute to disease prevention and treatment. In the context of sustainable development, there is growing interest in new technologies for isolating organic calcium salts from marine bioresources for medicinal use. Aim. To develop and compare technologies for extraction of organic calcium from the shells of Arctic shrimp Pandalus borealis (a waste of food industry), and to evaluate the composition and purity of the obtained products. Materials and methods. The shells of cooked-frozen Arctic shrimps Pandalus borealis were processed by two calcium extraction technologies: (1) direct demineralization with organic acids (citric, malic and lactic) and (2) preliminary defatting of the raw material with ethanol followed by demineralization. Quantitative analysis of calcium (Ca) and other elements was performed by Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES). A hazard quotient (HQ) was calculated for safety assessments. Results and discussion. It was found that the maximum calcium yield was achieved after demineralization with citric acid (153.0 ± 10.3 mg Ca/g). Malic and lactic acids showed less efficiency. Preliminary defatting reduced the Ca yield by an average of 2.2 %; however, the lipid fraction is of interest as a source of carotenoids and other natural lipids. Toxic elements (Pb, Cd, Ni, Cr, As) were either not detected or their concentrations were below the limit of quantification. The content of associated elements (Mg, Zn, Fe, Cu, and Mn) was below the toxic level (calculated HQ < 1). Consumption of isolated Ca products will provide enrichment of the dietary intake with certain microelements. Conclusion. The shells of Arctic shrimps are a valuable source of organic calcium for the environmentally friendly production of physiologically balanced calcium salts – calcium citrate, malate, and lactate. The resulting calcium salts are not polluted with toxic elements and can be used in the pharmaceutical and food industries.


  • Open Access

    The influence of the molecular weight of hyaluronic acid on the mangiferin release kinetics from the polymer matrix

    by P. P. Snetkov, R. O. Shaikenov, V. I. Klimshina, Yu. E. Generalova, S. N. Morozkina

    Introduction. Currently, the use of natural biologically active agents (BAA) as effective antibacterial drugs for both external and internal use is becoming widespread. Polyphenol mangiferin, extracted from the leaves of the Mangifera indica plant, is the most attractive BAA. Despite high antimicrobial activity against gram-positive and gram-negative strains of bacteria, the use of mangiferin is limited by its low aqueous solubility. To increase solubility and, accordingly, bioavailability, various approaches are used, in particular, encapsulation in polymer and biopolymer matrices. One of the promising biopolymers for the encapsulation of biologically active substances is hyaluronic acid, which is completely biocompatible with the tissues of a living organism and is capable of complete biodegradation under the influence of enzymes (hyaluronidases).Aim. Study of the release kinetics of the biologically active agent (mangiferin) from a polymer matrix based on hyaluronic acid with different molecular weights.Materials and methods. Polymer films obtained by casting method from 1.5 wt.% forming solutions of hyaluronic acid with a molecular weight of 1.30 and 2.48 MDa with different contents of mangiferin were used as the objects of the study. The weight ratio of hyaluronic acid to mangiferin varied from 5 to 25. Released mangiferin was measured by UV/Vis spectrophotometry at a wavelength of 237 nm. A phosphate buffered saline with pH 7.4 was used as a model medium. The mangiferin release kinetic was assessed using various mathematical models.Results and discussion. Mangiferin release kinetic from a polymer matrix based on hyaluronic acid has a release sigmoidal pattern. The release mechanism has a complex nature of the Super Case II transport type, with the exception of a sample with a low content of mangiferin and hyaluronic acid with molecular weight equal to 1.3 MDa, for which an abnormal release pattern is detected (non-Fickian diffusion), due to the hydrophilic nature of hyaluronic acid, the rapid swelling of the polymer matrix, as well as a significant leading in the diffusion of mangiferin compared to the relaxation rate of the polymer. The most suitable model is the Weibull model, which describes the mangiferin release kinetics with greater accuracy compared to other mathematical models.Conclusion. The results obtained indicate the potential possibility of using the developed polymer films as biomedical materials for external use, which provide transdermal delivery of pharmaceutical agents. The authors of the study are planning to develop a methodology for prolonged and controlled release of a loaded biologically active agent, including by various cross-linking agents.

  • Open Access

    Electrospun Hyaluronan-Based Nanofibers with Mangiferin: Preparation, Morphology, and Drug Release Kinetics

    by Roman Shaikenov, Vladislava Klimshina, Yuliya Generalova, Polina Serbun, Anna Kosova, Maksim Dorogov, Svetlana Morozkina, Petr Snetkov

    The rise in antibiotic-resistant bacterial infections is a major global health concern. The search for natural compounds that inhibit the growth of pathogens is becoming urgent. One such compound is mangiferin, a non-toxic polyphenolic compound derived mainly from Mangifera indica. In addition to antibacterial properties, it exhibits anticancer, antioxidant, immunomodulatory, analgesic and other activities. However, the clinical application of mangiferin is limited by poor solubility and bioavailability. This study describes mangiferin-loaded electrospun nanofibers based on high-molecular-weight hyaluronic acid. The nanofibers improve mangiferin delivery and possess favorable morphological characteristics and drug release kinetics, making them promising candidates for effective antibacterial dressings. This study found that an increase in the mangiferin content of the fibers led to an increase in the average diameter of the fibers. It was also found that nanofibers with different mangiferin content have similar release kinetics with an anomalous non-Fickian transport pattern: most of the mangiferin is released within 10–15 min.


  • Open Access

    Study of the Dynamics of Diflunisal Release from a Polymer Matrix

    by P. A. Mihajlova, A. A. Adamova, Yu. E. Generalova, P. P. Snetkov, S. N. Morozkina

    Introduction. The effectiveness of diflunisal in the treatment of cardiac amyloidosis has been clinically proven. Currently, only tablet forms of diflunisal are registered in the world, however, long-term use of NSAIDs leads to characteristic side effects. Therefore, delivery systems for diflunisal (including a form for external use) are now being actively developed to reduce side effects and improve its bioavailability.Aim. Research of the dynamics of release of the active substance diflunisal from the polymer matrix of hyaluronic acid.Materials and methods. The objects of the study are diflunisal gels in hyaluronic acid with a concentration of the main substance of 0.093, 0.14, 0.19 and 0.25 %. Quantitative determination was carried out by reverse-phase HPLC using a Prontosil C18, 120-5, 75 × 2 mm chromatographic column, thermostatically controlled at 40 °C. Eluent: phosphate buffer solution (PBS) with pH 3.0 and acetonitrile (30 : 70), flow rate 0.1 ml/min. Eluates were detected at wavelengths of 230, 270, 310 nm.Results and discussion. During the work, a method (HPLC) was selected and a method for determining diflunisal in a HA matrix was developed. The delivery system under study significantly increases the solubility of diflunisal in an aqueous solution compared to the dissolution of the substance. The release of the active substance from the matrices was carried out in a phosphate buffer solution with pH 7.6. The release rate for all samples exceeded 90 % after 3 hours after the start of the experiment, with most of the active substance released within an hour.Conclusion. The data obtained suggest that the release profile is characteristic of biodegradable matrices and diffusion-controlled delivery systems. Complete extraction of diflunisal from HA was achieved using PBS with pH 7.6 as a dissolution medium.


  • Open Access

    Ascophyllum nodosum (Linnaeus) Le Jolis from Arctic: Its Biochemical Composition, Antiradical Potential, and Human Health Risk

    by Ekaterina D. Obluchinskaya, Olga N. Pozharitskaya, Elena V. Gorshenina, Anna V. Daurtseva, Elena V. Flisyuk, Yuliya E. Generalova, Inna I. Terninko, Alexander N. Shikov

    Ascophyllum nodosum is a brown seaweed common in Arctic tidal waters. We have collected A. nodosum samples from the Barents Sea (BS), Irminger Sea (IS), and Norwegian Sea (NS) in different reproductive stages and have evaluated their biochemical composition, radical scavenging potential, and health risks. The total content of dominating carbohydrates (fucoidan, mannitol, alginate, and laminaran) ranged from 347 mg/g DW in NS to 528 mg/g DW in BS. The proportion of two main structural monosaccharides of fucoidan (fucose and xylose) differed significantly between the seas and reproductive phase, reaching a maximum at the fertile phase in the BS sample. Polyphenols and flavonoids totals were highest in NS A. nodosum samples and increased on average in the following order: BS < IS < NS. A positive correlation of free radical scavenging activity for seaweed extracts with polyphenols content was observed. The concentration of elements in A. nodosum from the Arctic seas region was in the following order: Ca > Mg > Sr > Fe > Al > Zn > As total > Rb > Mn > Ba > Cu > Co. Seaweeds from BS had the lowest metal pollution index (MPI) of 38.4. A. nodosum from IS had the highest MPI of 83. According to the calculated target hazard quotient (THQ) and hazard index (HI) values, Arctic A. nodosum samples pose no carcinogenic risk to adult and child health and are safe for regular consumption. Our results suggest that the Arctic A. nodosum has a remarkable potential for food and pharmaceutical industries as an underestimated source of polysaccharides, polyphenols, and flavonoids.


  • Open Access

    Optimization of the Method for Spectrofluorimetric Determination of Aluminum Impurities in Substances

    by E. V. Vishnyakov, A. A. Tolstikova, J. E. Generalova, A. K. Kaldybaeva, I. I. Terninko

    Introduction. Evaluation of the content of impurities is the most important step in confirming the safety and efficacy in the quality control of the medicinal product. Aluminum, being an acceptable impurity in a number of pharmaceutical substances, can adversely affect the human body, as a result of which its content is normalized. The admixture of aluminum in the State Pharmacopoeia of the Russian Federation XV is determined by the spectrofluorimetric method using the ligand – 8-hydroxyquinoline in chloroform. In the present work, it is proposed to replace 8-hydroxyquinoline with the more accessible rutin, which also forms fluorescent complexes with metals. This approach involves the exclusion of the stage of extraction of the aluminum complex into chloroform from sample preparation, which improves the accuracy of the technique, and the replacement of chloroform has a positive effect on safety.Aim. To create an alternative approach for the spectrofluorimetric determination of aluminum impurities using rutin and "potassium chloride" as an active pharmaceutical ingredient.Materials and methods. The following substances and reagents were used as research materials: CRS of aluminum ion 1 mg/ml (LLC "EKROSHIM", Russia), CRS of iron ion (II) 1 mg/ml (LLC "EKROSHIM", Russia), CRS of zinc ion 1 mg/ml (LLC "EKROSHIM", Russia), CRS of lead-ion 1 mg/ml (LLC "EKROSHIM", Russia), CRS nickel-ion 1 mg/ml (LLC "EKROSHIM", Russia), CRS copper-ion 1 mg/ml (LLC "EKROSHIM", Russia), chromium (III) cation standard 1 mg/ml (imp., Sigma-Aldrich, USA) rutin (imp., Sichuan Guangsong Pharmaceutical Co., Ltd., China), ammonium acetic acid (imp., Molekula GmbH, Germany), glacial acetic acid (chemically pure, JSC "Base No. 1 Himreaktivov", Russia), potassium chloride (pharmaceutical substance, LLC "MZHR", Russia). The spectrofluorimetric study was carried out on an FL 6500 instrument (PerkinElmer Inc., USA). The aluminum impurity content was also evaluated using an Optima 8000 inductively coupled plasma atomic emission spectrometer (ICP AES) (PerkinElmer Inc., USA) and a Multi-Element Solution standard sample (PerkinElmer Inc., USA).Results and discussion. The approach given in the article eliminates the use of 8-hydroxyquinoline in chloroform and replaces it with rutin in 70 % ethyl alcohol. The aluminum-rutin complex has an excitation wavelength at 445 nm and an emission wavelength at 565 nm. The proposed method was tested on the substance "Potassium chloride" to assess the indicator "Aluminum", the content of which should not exceed 0.0001 %. Method validation was carried out according to three parameters "Specificity", "Linearity" and "Limit of detection". Comparison of the data obtained was carried out using atomic emission spectroscopy, during which the relevance of the technique was proved.Conclusion. An ergonomic approach has been developed for the spectrofluorimetric determination of aluminum impurities using rutin with approbation on the substance "Potassium chloride". The results obtained during the experiment were confirmed by the ICP AES method.